Cytotheryx is a biotechnology company focused on creating functional human liver cells at scale for research, development, and potential therapies. Their platform technology, including a bio-incubator and liver cell products, aims to deliver high-quality hepatocytes to address the rising burden of liver disease. Based in the United States, with activities highlighted around collaborations and partnerships, the company emphasizes advancing liver biology and cell-based solutions for medical research and treatment.